Reference number : 172-2019-2020-Q2-933784, amendment number : , agreement type : C, recipient legal name : Mediphage Bioceuticals, Inc., recipient country : CA, recipient province : ON, recipient city : Toronto|Toronto, recipient postal code : M5G 0B7, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Scale-up and Optimization of Linear Covalently Closed DNA Ministrings (msDNA) Production, agreement title french : Mise à l'échelle et optimisation de la production de minicordes d'ADN linéaire fermées par covalence, agreement number : 933784, agreement value : 125000.0, agreement start date : 2019-07-15, agreement end date : 2020-07-31, description english : This project will enable large-scale production of ministring DNA transgene delivery vector by improving fermentation and purification efficiency. Increased production capacity will support Mediphage's genetic medicine program., description french : Ce projet permettra la production à grande échelle de vectrice minicorde d'ADN transgénique en améliorant l'efficacité de la fermentation et de la purification. L'augmentation de la capacité de production appuiera le programme de médecine génétique de Mediphage., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada